LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers

by Christina Black | Jul 28, 2022

Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD-L1 IHC

by Christina Black | Jul 28, 2022

Cancer testis antigen burden: pan-cancer distribution and survival implications

by Christina Black | Apr 10, 2022

Checkpoint coexpression landscape in gastroesophageal adenocarcinoma

by Christina Black | Mar 8, 2022

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors

by Christina Black | Dec 3, 2021